Jeffrey Abbey, President and CEO of Argos Therapeutics will provide the keynote address for ORIED’s annual Research Retreat at PNC Arena on April 5. Argos, an immuno-oncology company located in Durham, NC, develops and commercializes individualized immunotherapies based on the Arcelis® precision immunotherapy technology platform.
Morning: The State of Research at NC State and Future Directions
With updates from
Lunch and Keynote
Afternoon: Research Administration Updates
Jeffrey D. Abbey has served as President and Chief Executive Officer and a member of the board of directors of Argos Therapeutics since February 2010. Mr. Abbey served in various other positions at the company from September 2002 to February 2010, including Vice President of Business Development from February 2004 to January 2009 and Chief Business Officer from January 2009 to February 2010. Prior to joining Argos, Mr. Abbey served as Vice President of Business Development and Finance at Internet Appliance Network, an information technology company, from 1999 to 2001. Mr. Abbey was a partner at Eilenberg and Krause, LLP, a corporate law firm, from 1994 to 1999. Mr. Abbey received an A.B. in mathematical economics from Brown University and an M.B.A. and J.D. from the University of Virginia.